Clinical trial
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
NCT03344653 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
- Lead sponsor
- Medtronic Vascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 2, 2017
- Completion date
- October 9, 2020
- Enrollment
- 2,000 (actual)
- Sites
- 89
Conditions
As the registry lists them; a condition with its own page is linked.